Miguel Regueiro

Nov 15, 2024 | gastroendonews.com | Miguel Regueiro

Professor of MedicineChief of the Digestive Disease InstituteCleveland Clinic, ClevelandProspective studies that directly compare the efficacy of two different medications remain rare in our field, although they do exist and should become more common in future years. Although such studies are ideal for guiding treatment decisions, well-designed retrospective studies that compare the benefits of two medications are also helpful.

Feb 21, 2024 | healio.com | Miguel Regueiro |Monica Stonehill |Heather Biele

You've successfully added Gastroenterology: Inflammatory Bowel Disease to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Nov 20, 2023 | onlinelibrary.wiley.com | Aakash Desai |Miguel Regueiro |Gursimran Kochhar

We thank Dr. Chang et al. for their interest in our papers.1, 2 We appreciate their comments and here provide clarifications regarding their concerns about the study design. The primary outcome of the study was to assess the risk of hospitalisation requiring intravenous steroid use and/or colectomy after starting a second-line therapy. Patients could have met the primary outcome if they received intravenous steroids, underwent colectomy or both.

Mar 10, 2023 | physiciansweekly.com | Rebecca Shover |Miguel Regueiro

Fatigue in patients with Crohn’s disease and ulcerative colitis was associated with various factors and resulted in poorer QOL. “The study was prompted by the fact that fatigue is a common symptom complaint among patients with Crohn’s disease and ulcerative colitis, but is poorly understood,” Miguel Regueiro, MD, explains.